Rikke Hedegaard D.
- Country
- Denmark
- Department
- Oncology
Research Overview
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)
- Evaluation of CC-90010 in Combination with Standard Therapy in Patients with Newly Diagnosed WHO Grade IV Glioblastoma Post-Tumor Resection
Data & Insights
Has run more than one trial at 12 of 40 partner sites.
Specializations
Neuro-Oncology Focus
Specializes in investigating innovative therapeutic approaches for glioblastoma, with particular emphasis on WHO Grade IV brain tumors. Conducts research exploring treatment options for patients following surgical intervention.
- Post-surgical therapeutic interventions
- High-grade glioma management
- Brain tumor therapeutics
Active in evaluating treatment outcomes for patients with newly diagnosed brain malignancies.
Surgical Oncology
Focuses on treatment strategies for patients who have undergone tumor resection procedures. Investigates therapeutic approaches following both complete and partial surgical interventions.
- Post-operative care protocols
- Tumor resection outcomes
- Surgical intervention efficacy
Examines the integration of novel therapeutic agents in post-surgical treatment plans.
Experimental Therapeutics
Investigates the potential of novel therapeutic compounds in conjunction with standard treatment protocols. Evaluates combination therapy approaches for brain cancer management.
- Combination therapy assessment
- Treatment optimization
- Drug therapy integration
Studies the effectiveness of experimental agents in enhancing conventional treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.